Mink Brook Asset Management »

Lipocine shares owned by Mink Brook Asset Management

Quarter-by-quarter ownership of Lipocine (LPCN) shares owned by Mink Brook Asset Management from 13F filings

Historical chart of Mink Brook Asset Management investment in Lipocine

Tip: Access up to 7 years of quarterly data

All positions including Lipocine held by Mink Brook Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lipocine by Mink Brook Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $534k 67k 7.99

More positions owned by Mink Brook Asset Management

Envela Corporation Comm (ELA)
Bank7 Corp Comm (BSVN)
Acme United Corp Comm (ACU)
American Integrity Insurance Comm (AII)
Dlh Holdings Corp Comm (DLHC)
Ascent Industries Comm (ACNT)
Currency Exchange Internatio Comm (CURN)
Rimini Street Comm (RMNI)
Butler National Corp Comm (BUKS)
Astro-med Comm (ALOT)
Star Equity Holdings Comm (STRR)
Legacy Education Comm (LGCY)
Heritage Global Comm (HGBL)
Friedman Industries Comm (FRD)
Mdxhealth Sa- Adrs (MDXH)

View all positions for Mink Brook Asset Management

Top funds holding Lipocine

Ikarian Capital
Squadron Capital Management
Diadema Partners
Vanguard Group
Vanguard Capital Management
AIGH Capital Management
Stempoint Capital
Boothbay Fund Management
Seven Fleet Capital Management
Birchview Capital
BlackRock
Mink Brook Asset Management
Geode Capital Management
Renaissance Technologies
Two Sigma Investments

View all funds holding Lipocine